• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

密度泛函理论在药物制剂分子工程中的应用。

Application of Density Functional Theory to Molecular Engineering of Pharmaceutical Formulations.

作者信息

Guan Haoyue, Sun Huimin, Zhao Xia

机构信息

National Institute for Food and Drug Control, Beijing 100050, China.

出版信息

Int J Mol Sci. 2025 Apr 1;26(7):3262. doi: 10.3390/ijms26073262.

DOI:10.3390/ijms26073262
PMID:40244098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11989887/
Abstract

This review systematically examines the pivotal applications of the Density Functional Theory (DFT) in drug formulation design, emphasizing its capability to elucidate molecular interaction mechanisms through quantum mechanical calculations. By solving the Kohn-Sham equations with precision up to 0.1 kcal/mol, DFT enables accurate electronic structure reconstruction, providing theoretical guidance for optimizing drug-excipient composite systems. In solid dosage forms, DFT clarifies the electronic driving forces governing active pharmaceutical ingredient (API)-excipient co-crystallization, predicting reactive sites and guiding stability-oriented co-crystal design. For nanodelivery systems, DFT optimizes carrier surface charge distribution through van der Waals interactions and π-π stacking energy calculations, thereby enhancing targeting efficiency. Furthermore, DFT combined with solvation models (e.g., COSMO) quantitatively evaluates polar environmental effects on drug release kinetics, delivering critical thermodynamic parameters (e.g., ΔG) for controlled-release formulation development. Notably, DFT-driven co-crystal thermodynamic analysis and pH-responsive release mechanism modeling substantially reduce experimental validation cycles. While DFT faces challenges in dynamic simulations of complex solvent environments, its integration with molecular mechanics and multiscale frameworks has achieved computational breakthroughs. This work offers interdisciplinary methodology support for accelerating data-driven formulation design.

摘要

本综述系统地研究了密度泛函理论(DFT)在药物制剂设计中的关键应用,强调了其通过量子力学计算阐明分子相互作用机制的能力。通过精确求解Kohn-Sham方程,精度可达0.1 kcal/mol,DFT能够实现准确的电子结构重建,为优化药物-辅料复合体系提供理论指导。在固体剂型中,DFT阐明了控制活性药物成分(API)-辅料共结晶的电子驱动力,预测反应位点并指导面向稳定性的共晶设计。对于纳米递送系统,DFT通过范德华相互作用和π-π堆积能计算优化载体表面电荷分布,从而提高靶向效率。此外,DFT与溶剂化模型(如COSMO)相结合,定量评估极性环境对药物释放动力学的影响,为控释制剂开发提供关键的热力学参数(如ΔG)。值得注意的是,DFT驱动的共晶热力学分析和pH响应释放机制建模大大减少了实验验证周期。虽然DFT在复杂溶剂环境的动态模拟中面临挑战,但其与分子力学和多尺度框架的整合已取得计算上的突破。这项工作为加速数据驱动的制剂设计提供了跨学科的方法支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c019/11989887/04157a77afdc/ijms-26-03262-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c019/11989887/eee8e2a6f3b0/ijms-26-03262-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c019/11989887/133121ec69e3/ijms-26-03262-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c019/11989887/9ba89f278cb0/ijms-26-03262-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c019/11989887/04157a77afdc/ijms-26-03262-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c019/11989887/eee8e2a6f3b0/ijms-26-03262-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c019/11989887/133121ec69e3/ijms-26-03262-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c019/11989887/9ba89f278cb0/ijms-26-03262-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c019/11989887/04157a77afdc/ijms-26-03262-g004.jpg

相似文献

1
Application of Density Functional Theory to Molecular Engineering of Pharmaceutical Formulations.密度泛函理论在药物制剂分子工程中的应用。
Int J Mol Sci. 2025 Apr 1;26(7):3262. doi: 10.3390/ijms26073262.
2
Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?将晶型和聚合型辅料组合在原料药固体分散体中-机遇还是风险?
Eur J Pharm Biopharm. 2021 Jan;158:323-335. doi: 10.1016/j.ejpb.2020.11.025. Epub 2020 Dec 6.
3
Pharmaceutical excipients in pediatric and geriatric drug formulations: safety, efficacy, and regulatory perspectives.儿科和老年药物制剂中的药用辅料:安全性、有效性及监管视角
Pharm Dev Technol. 2025 Jan;30(1):1-9. doi: 10.1080/10837450.2024.2441181. Epub 2024 Dec 14.
4
Solubility Enhancement of Active Pharmaceutical Ingredients through Liquid Hydrotrope Addition: A Thermodynamic Analysis.通过添加液体助溶剂提高活性药物成分的溶解度:热力学分析
Mol Pharm. 2025 Mar 3;22(3):1408-1418. doi: 10.1021/acs.molpharmaceut.4c01117. Epub 2025 Feb 13.
5
Computer-driven formulation development of Ginsenoside Rh2 ternary solid dispersion.人参皂苷Rh2三元固体分散体的计算机驱动制剂研发
Drug Deliv Transl Res. 2025 Feb;15(2):700-716. doi: 10.1007/s13346-024-01628-4. Epub 2024 Jun 24.
6
Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology.利用无定形固体分散技术解决研发阶段的药物制剂问题。
Recent Adv Drug Deliv Formul. 2024;18(2):79-99. doi: 10.2174/0126673878271641231201065151.
7
Predicting Drug-Polymer Compatibility in Amorphous Solid Dispersions by MD Simulation: On the Trap of Solvation Free Energies.通过分子动力学模拟预测无定形固体分散体中药物-聚合物的相容性:关于溶剂化自由能的陷阱
Mol Pharm. 2025 Feb 3;22(2):760-770. doi: 10.1021/acs.molpharmaceut.4c00810. Epub 2024 Nov 25.
8
Investigation of Drug-Excipient Interactions in Biclotymol Amorphous Solid Dispersions.研究双羟萘酸曲美布汀无定形固体分散体中的药物-赋形剂相互作用。
Mol Pharm. 2018 Mar 5;15(3):1112-1125. doi: 10.1021/acs.molpharmaceut.7b00993. Epub 2018 Jan 29.
9
Managing active pharmaceutical ingredient raw material variability during twin-screw blend feeding.在双螺杆共混供料过程中管理原料药活性成分的变异性。
Eur J Pharm Biopharm. 2019 Feb;135:49-60. doi: 10.1016/j.ejpb.2018.12.012. Epub 2018 Dec 22.
10
Influence of dissolution-modifying excipients in various pharmaceutical formulations on electronic tongue results.不同药物制剂中溶出改性辅料对电子舌结果的影响。
Talanta. 2017 Jan 1;162:203-209. doi: 10.1016/j.talanta.2016.10.018. Epub 2016 Oct 4.

引用本文的文献

1
A review of herbal therapeutics for the prevention and management of poxvirus infections.用于预防和治疗痘病毒感染的草药疗法综述。
Arch Microbiol. 2025 Jun 25;207(8):186. doi: 10.1007/s00203-025-04367-3.
2
Identification of Hydroxyl and Polysiloxane Compounds via Infrared Absorption Spectroscopy with Targeted Noise Analysis.通过具有目标噪声分析的红外吸收光谱法鉴定羟基和聚硅氧烷化合物
Polymers (Basel). 2025 May 30;17(11):1533. doi: 10.3390/polym17111533.
3
Crystallographic and DFT study of novel dimethoxybenzene derivatives.新型二甲氧基苯衍生物的晶体学与密度泛函理论研究

本文引用的文献

1
Mixed Micellization and Density Functional Theory (DFT) Studies on the Molecular Interactions between Gemini and Nonionic Surfactants.双子表面活性剂与非离子表面活性剂分子间相互作用的混合胶束化及密度泛函理论(DFT)研究
J Oleo Sci. 2025;74(1):47-59. doi: 10.5650/jos.ess24095.
2
Quantum DFT analysis and molecular docking investigation of various potential breast cancer drugs.多种潜在乳腺癌药物的量子密度泛函理论分析与分子对接研究
J Mater Chem B. 2024 Dec 18;13(1):218-238. doi: 10.1039/d4tb01803f.
3
Supramolecular architecture of theophylline polymorphs, monohydrate and co-crystals with iodine: study from the energetic viewpoint.
BMC Chem. 2025 May 14;19(1):127. doi: 10.1186/s13065-025-01496-0.
茶碱多晶型物、一水合物及与碘的共晶体的超分子结构:从能量角度的研究
RSC Adv. 2024 Sep 18;14(41):29774-29788. doi: 10.1039/d4ra04368e.
4
Incorporating Synthetic Accessibility in Drug Design: Predicting Reaction Yields of Suzuki Cross-Couplings by Leveraging AbbVie's 15-Year Parallel Library Data Set.在药物设计中纳入合成可及性:利用 AbbVie 长达 15 年的平行文库数据集预测铃木交叉偶联反应产率。
J Am Chem Soc. 2024 Jun 5;146(22):15070-15084. doi: 10.1021/jacs.4c00098. Epub 2024 May 20.
5
Accelerating reliable multiscale quantum refinement of protein-drug systems enabled by machine learning.借助机器学习加速可靠的蛋白质-药物系统的多尺度量子细化。
Nat Commun. 2024 May 16;15(1):4181. doi: 10.1038/s41467-024-48453-4.
6
Computational Chemistry: Prediction of Compound Accessibility of Targeted Synthesized Compounds.计算化学:靶向合成化合物的可及性预测
Med Chem. 2025;21(5):334-344. doi: 10.2174/0115734064293464240405050455.
7
Synthesis, molecular docking analysis, molecular dynamic simulation, ADMET, DFT, and drug likeness studies: Novel Indeno[1,2-b]pyrrol-4(1H)-one as SARS-CoV-2 main protease inhibitors.合成、分子对接分析、分子动力学模拟、ADMET、DFT 和类药性研究:新型茚并[1,2-b]吡咯-4(1H)-酮作为 SARS-CoV-2 主蛋白酶抑制剂。
PLoS One. 2024 Mar 22;19(3):e0299301. doi: 10.1371/journal.pone.0299301. eCollection 2024.
8
Overcoming the barrier of orbital-free density functional theory for molecular systems using deep learning.利用深度学习克服分子体系无轨道密度泛函理论的障碍。
Nat Comput Sci. 2024 Mar;4(3):210-223. doi: 10.1038/s43588-024-00605-8. Epub 2024 Mar 11.
9
NMR crystallography of amino acids.氨基酸的 NMR 晶体学。
Solid State Nucl Magn Reson. 2024 Apr;130:101921. doi: 10.1016/j.ssnmr.2024.101921. Epub 2024 Feb 19.
10
Density functional theory methods applied to homogeneous and heterogeneous catalysis: a short review and a practical user guide.应用于均相和多相催化的密度泛函理论方法:简要综述与实用用户指南
Phys Chem Chem Phys. 2024 Mar 6;26(10):7950-7970. doi: 10.1039/d4cp00266k.